Acquired von Willebrand disease (aVWD) is frequently observed in patients with the need for extracorporeal membrane oxygenation (ECMO). aVWD can be treated by plasma-derived concentrates containing factor VIII (FVIII) and/or von Willebrand factor (VWF) and recombinant VWF concentrate as well as adjuvant therapies such as tranexamic acid and desmopressin. However. all of these therapeu... https://www.lightemupsequences.com/hot-mega-Esko-Nexus-HeightMaster-Vented-Safety-Helmet-big-savings/